ciprofloxacin has been researched along with Infections, Staphylococcal Skin in 13 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral levofloxacin was compared to oral ciprofloxacin in a Staphylococcus aureus subcutaneous abscess model in rabbits." | 7.70 | Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. ( Amaratunga, D; Barrett, JF; Fernandez, J; Frosco, M; Licata, L, 1999) |
| "Oral levofloxacin was compared to oral ciprofloxacin in a Staphylococcus aureus subcutaneous abscess model in rabbits." | 3.70 | Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess. ( Amaratunga, D; Barrett, JF; Fernandez, J; Frosco, M; Licata, L, 1999) |
| "Orbifloxacin was tested at different concentrations for killing rate against five isolates obtained from pyoderma cases and against a reference strain (Staphylococcus aureus ATCC 29213)." | 1.32 | In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. ( Etoré, F; Ganière, JP; Médaille, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Szumowski, JD | 1 |
| Cohen, DE | 1 |
| Kanaya, F | 1 |
| Mayer, KH | 1 |
| Kumar, S | 1 |
| Pal, S | 1 |
| Thakur, J | 1 |
| Rani, P | 1 |
| Rana, K | 1 |
| Kar, A | 1 |
| Kar, R | 1 |
| Mehta, D | 1 |
| Jha, SK | 1 |
| Pradhan, MK | 1 |
| Jain, D | 1 |
| Rajput, K | 1 |
| Mishra, S | 1 |
| Ganguli, M | 1 |
| Srivastava, A | 1 |
| Dasgupta, U | 1 |
| Patil, VS | 1 |
| Bajaj, A | 1 |
| Sun, M | 1 |
| Zhu, C | 1 |
| Long, J | 1 |
| Lu, C | 1 |
| Pan, X | 1 |
| Wu, C | 1 |
| Gao, G | 1 |
| Jiang, YW | 1 |
| Jia, HR | 1 |
| Wu, FG | 1 |
| Cano García, ME | 1 |
| Monteagudo Cimiano, I | 1 |
| Mellado Encinas, P | 1 |
| Ortega Álvarez, C | 1 |
| Baek, YS | 1 |
| Jeon, J | 1 |
| Ahn, JW | 1 |
| Song, HJ | 1 |
| Tan, M | 1 |
| Lee, JS | 1 |
| Pan, JY | 1 |
| Ganière, JP | 1 |
| Médaille, C | 1 |
| Etoré, F | 1 |
| Brezzo, C | 1 |
| Cecchini, D | 1 |
| Biscione, F | 1 |
| Orduna, T | 1 |
| Costa, N | 1 |
| Quinteros, M | 1 |
| Cooke, FJ | 1 |
| Howard, JC | 1 |
| Hugh-Jones, C | 1 |
| Brown, NM | 1 |
| Kotilainen, P | 1 |
| Huovinen, S | 1 |
| Järvinen, H | 1 |
| Aro, H | 1 |
| Huovinen, P | 1 |
| Fernandez, J | 1 |
| Barrett, JF | 1 |
| Licata, L | 1 |
| Amaratunga, D | 1 |
| Frosco, M | 1 |
| Mayberry-Carson, KJ | 1 |
| Tober-Meyer, B | 1 |
| Gill, LR | 1 |
| Lambe, DW | 1 |
| Mayberry, WR | 1 |
1 trial available for ciprofloxacin and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
Epidemiology of the colonization of inpatients and outpatients with ciprofloxacin-resistant coagulase-negative staphylococci.
Topics: Anti-Infective Agents; Carrier State; Ciprofloxacin; Coagulase; Cross Infection; Drug Resistance, Mi | 1995 |
12 other studies available for ciprofloxacin and Infections, Staphylococcal Skin
| Article | Year |
|---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Ma | 2007 |
Nonimmunogenic Hydrogel-Mediated Delivery of Antibiotics Outperforms Clinically Used Formulations in Mitigating Wound Infections.
Topics: Animals; Anti-Bacterial Agents; Cholic Acids; Ciprofloxacin; Dipeptides; Drug Carriers; Drug Liberat | 2021 |
PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Dru | 2020 |
Near-infrared light-controllable on-demand antibiotics release using thermo-sensitive hydrogel-based drug reservoir for combating bacterial infection.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Delayed-Action Preparations; Female; Hydrog | 2019 |
[Methicillin-resistant Staphylococcus aureus carrying the mecC gene in a patient with a wound infection].
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Debridement; Drug Resistance, Mul | 2015 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciproflo | 2016 |
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agen | 2016 |
In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Micro | 2004 |
[Community-acquired methicillin-resistant Staphylococcus aureus disseminated disease].
Topics: Abscess; Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Humans; Male; M | 2006 |
Meticillin-resistant Staphylococcus aureus in the community: homeless are also at risk.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Ill-Housed Persons; Methicill | 2008 |
Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Levofloxacin; Micr | 1999 |
Effect of ciprofloxacin on subcutaneous abscesses induced with Staphylococcus epidermidis and a foreign body implant in the mouse.
Topics: Abscess; Animals; Ciprofloxacin; Disease Models, Animal; Foreign Bodies; Injections, Subcutaneous; M | 1988 |